Why plasma should not be used to study paraoxonase
- 1 January 1998
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 136 (1) , 195-196
- https://doi.org/10.1016/s0021-9150(97)00197-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteinsCurrent Opinion in Lipidology, 1996
- A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease.Journal of Clinical Investigation, 1995
- Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetesThe Lancet, 1995
- Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrationsBiochemical Journal, 1994
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993
- The molecular basis of the human serum paraoxonase activity polymorphismNature Genetics, 1993
- Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoproteinFEBS Letters, 1991
- Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitusAtherosclerosis, 1991
- ‘A’-esterase activity in the lipoprotein fraction of sheep serumBiochemical Pharmacology, 1981
- Hydrolysis of Paraoxon in Mammalian BloodNature, 1961